Clinical impact of post‐progression survival on overall survival in patients receiving nivolumab monotherapy as a second‐line treatment for advanced non‐small cell lung cancer

BACKGROUND: The effect of second‐line treatment on overall survival (OS) may be affected by subsequent treatment in patients with non‐small cell lung cancer (NSCLC); however, in such patients, the correlation between post‐progression survival (PPS) and OS is unclear. Our study assessed the correlati...

Descripción completa

Detalles Bibliográficos
Autores principales: Imai, Hisao, Yamaguchi, Ou, Mori, Keita, Hashimoto, Kosuke, Akagami, Tomoe, Shinomiya, Shun, Miura, Yu, Shiono, Ayako, Mouri, Atsuto, Kaira, Kyoichi, Kobayashi, Kunihiko, Kagamu, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046034/
https://www.ncbi.nlm.nih.gov/pubmed/33626218
http://dx.doi.org/10.1111/1759-7714.13886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046034/
https://www.ncbi.nlm.nih.gov/pubmed/33626218
http://dx.doi.org/10.1111/1759-7714.13886

Ejemplares similares